Teva Escapes Merck's Patent Suit Over Generic Nasonex
A Delaware federal judge on Wednesday dismissed Merck Sharp & Dohme Corp.'s suit claiming Teva Pharmaceuticals USA Inc. is infringing its patent by intending to produce and sell a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article